Interleukin-21 receptor signalling is not critically required for imiquimod-induced psoriasiform dermatitis in mice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hee Joo | - |
dc.contributor.author | Kim, Sung Hee | - |
dc.contributor.author | Kim, Tae-Gyun | - |
dc.contributor.author | Park, Je Yun | - |
dc.contributor.author | Lee, Minseok | - |
dc.contributor.author | Kim, Dae Suk | - |
dc.contributor.author | Lee, Min-Geol | - |
dc.date.available | 2020-02-27T11:42:24Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2018-02 | - |
dc.identifier.issn | 0906-6705 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/4071 | - |
dc.description.abstract | Psoriasis is largely mediated by interleukin (IL)-23/T helper (Th) 17 axis, and IL-21 is a pleiotropic cytokine expressed by Th17 cells. Despite previously reported possible pathogenic roles of IL-21 in human psoriasis, we found that IL-21 receptor (IL-21R) signalling was not crucial for imiquimod-induced psoriatic inflammation, using IL-21R(-/-) mice. The severity of imiquimod-induced psoriatic manifestation and pro-inflammatory Th17 cytokine levels, IL-17A-producing T cells and CD4+ T cells, and in vitro IL-17A production by T cells after IL-23 stimulation was comparable between wild-type and IL-21R(-/-) mice. Collectively, IL-21R signalling was not critically involved in IMQ-induced psoriatic inflammation despite an increased IL-21 expression in the IMQ-treated mouse skin. Our data may represent the significant differences between human psoriasis and murine psoriasis model, and further studies using other models will be required to elucidate the role of IL-21 in psoriasis pathogenesis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.relation.isPartOf | EXPERIMENTAL DERMATOLOGY | - |
dc.subject | DELTA T-CELLS | - |
dc.subject | IL-21 | - |
dc.subject | DIFFERENTIATION | - |
dc.subject | COUNTERACTS | - |
dc.subject | SEVERITY | - |
dc.subject | BETA | - |
dc.subject | NK | - |
dc.title | Interleukin-21 receptor signalling is not critically required for imiquimod-induced psoriasiform dermatitis in mice | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000423679700013 | - |
dc.identifier.doi | 10.1111/exd.13481 | - |
dc.identifier.bibliographicCitation | EXPERIMENTAL DERMATOLOGY, v.27, no.2, pp.191 - 195 | - |
dc.identifier.scopusid | 2-s2.0-85040048327 | - |
dc.citation.endPage | 195 | - |
dc.citation.startPage | 191 | - |
dc.citation.title | EXPERIMENTAL DERMATOLOGY | - |
dc.citation.volume | 27 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Kim, Hee Joo | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | IL-17 | - |
dc.subject.keywordAuthor | IL-21 receptor knockout mouse | - |
dc.subject.keywordAuthor | IL-22 | - |
dc.subject.keywordAuthor | IL-23 | - |
dc.subject.keywordAuthor | psoriasis | - |
dc.subject.keywordPlus | DELTA T-CELLS | - |
dc.subject.keywordPlus | IL-21 | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | COUNTERACTS | - |
dc.subject.keywordPlus | SEVERITY | - |
dc.subject.keywordPlus | BETA | - |
dc.subject.keywordPlus | NK | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.